Allan Jonathan - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Allan Jonathan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-12-08
Sale
2025-12-10
4:24 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
3,978$32.28$128,41111,831
(Direct)
View
2025-12-04
Sale
2025-12-05
8:49 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
9,803$31.25$306,32215,809
(Direct)
View
2025-12-02
Sale
2025-12-03
8:20 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
4,576$30.22$138,26819,612
(Direct)
View
2025-10-03
Sale
2025-10-07
4:26 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
10,000$25.07$250,65046,631
(Direct)
View
2025-08-29
Sale
2025-09-03
5:50 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
22,117$20.11$444,80952,583
(Direct)
View
2025-08-18
Sale
2025-08-20
4:11 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
1,683$18.24$30,69523,948
(Direct)
View
2025-08-13
Sale
2025-08-15
4:31 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
13,712$15$205,68019,631
(Direct)
View
2025-03-18
Sale
2025-03-20
6:05 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
4,211$8.4852$35,731151,565
(Direct)
View
2024-12-09
Sale
2024-12-11
4:05 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
13,666$13.61$185,97821,476
(Direct)
View
2024-12-06
Sale
2024-12-10
7:01 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
9,696$12.78$123,89135,142
(Direct)
View
2024-05-20
Sale
2024-05-22
4:15 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
8,599$15.04$129,32728,399
(Direct)
View
2024-03-28
Sale
2024-04-01
4:14 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
5,126$13.2$67,6682,598
(Direct)
View
2024-03-19
Sale
2024-03-19
8:29 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
2,349$6.0986$14,32630,149
(Direct)
View
2023-06-21
Sale
2023-06-23
4:45 pm
Stoke Therapeutics Inc.STOKAllan Jonathan
General Counsel & Corp Sec
1,948$13.48$26,2520
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-12-03
Exercise
2025-12-05
8:49 pm
N/A
2025-12-03
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
6,000$015,809
(Direct)
View
2025-12-01
Exercise
2025-12-03
8:20 pm
N/A
2025-12-01
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
12,357$019,612
(Direct)
View
2025-10-03
Exercise
2025-10-07
4:26 pm
N/A
N/A
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
10,000$9.1546,631
(Direct)
View
2025-10-03
Exercise
2025-10-07
4:26 pm
N/A
2033-03-14
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
10,000$046,631
(Direct)
View
2025-08-29
Exercise
2025-09-03
5:50 pm
N/A
N/A
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
10,000$7.0752,583
(Direct)
View
2025-08-29
Exercise
2025-09-03
5:50 pm
N/A
2032-12-06
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
10,000$052,583
(Direct)
View
2025-08-14
Exercise
2025-08-18
8:24 pm
N/A
2026-08-14
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
6,000$043,631
(Direct)
View
2025-08-14
Option Award
2025-08-18
8:24 pm
N/A
2026-08-14
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
12,000$043,631
(Direct)
View
2025-03-20
Option Award
2025-03-20
6:05 pm
N/A
2035-03-19
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
120,000$0151,565
(Direct)
View
2025-03-15
Exercise
2025-03-18
4:11 pm
N/A
2027-03-15
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
13,475$068,726
(Direct)
View
2024-12-03
Exercise
2024-12-05
4:21 pm
N/A
2025-12-03
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
6,000$062,838
(Direct)
View
2024-12-03
Option Award
2024-12-05
4:21 pm
N/A
2025-12-03
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
12,000$062,838
(Direct)
View
2024-12-01
Exercise
2024-12-03
4:14 pm
N/A
2025-12-01
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
33,927$051,195
(Direct)
View
2024-03-27
Option Award
2024-06-07
4:37 pm
N/A
2034-03-26
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
60,000$060,000
(Direct)
View
2024-05-20
Exercise
2024-05-22
4:15 pm
N/A
N/A
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
8,599$7.0728,399
(Direct)
View
2024-05-20
Exercise
2024-05-22
4:15 pm
N/A
2032-12-06
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
8,599$028,399
(Direct)
View
2024-03-15
Exercise
2024-03-19
8:29 pm
N/A
2027-03-15
Stoke Therapeutics Inc.STOKAllan Jonathan
GENERAL COUNSEL & CORP SEC
7,475$030,149
(Direct)
View
2023-12-01
Option Award
2023-12-05
4:09 pm
N/A
2025-12-01
Stoke Therapeutics Inc.STOKAllan Jonathan
General Counsel & Corp Sec
46,284$046,284
(Direct)
View
2023-03-15
Option Award
2023-03-17
4:37 pm
N/A
2033-03-14
Stoke Therapeutics Inc.STOKAllan Jonathan
General Counsel & Corp Sec
74,700$074,700
(Direct)
View

Ownership
2023-03-17
3:40 pm
N/A
N/A
Stoke Therapeutics Inc.STOKAllan Jonathan
General Counsel & Corp Sec
0$0222,448
(Direct)
View